While the mechanism is yet to be elucidated, it is possible that CH influences cancer development through its cell–cell interactions with cancer cells, through impaired anti-tumor immune surveillance, by creating a proinflammatory milieu, or by promoting therapeutic resistance to cancer-directed treatment [125,127]. This evidence concerns the gene C4B and cancer.